Overview

SANCC: Clinical Trial Early Intervention

Status:
Not yet recruiting
Trial end date:
2023-04-01
Target enrollment:
Participant gender:
Summary
Subarachnoid neurocysticercosis (SANCC) is a severe infection of the brain by the tapeworm Taenia solium. People who have this infection are usually diagnosed late in the disease process leading to very poor prognosis. This trial studies the safety of early medical intervention in people who have SANCC but do not have symptoms. The trial will enroll 18 participants in Peru.
Phase:
Phase 2
Details
Lead Sponsor:
Oregon Health and Science University
Collaborators:
National Institute of Neurological Disorders and Stroke (NINDS)
Universidad Peruana Cayetano Heredia
Treatments:
Albendazole